報價延遲最少15分鐘:2026/04/29 02:19 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
9.96 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.33/0.86
|
|
企業價值
956.01M
|
| 資產負債 |
|
每股賬面淨值
2.72
|
| 現金流量 |
|
現金流量率
0.11
|
| 損益表 |
|
收益
573.28M
|
|
每股收益
7.43
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies. |
